Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1982 Jul;70(1):98–104. doi: 10.1172/JCI110608

Autologous mixed lymphocyte reaction in the peripheral blood and pleural effusions of cancer patients.

A Uchida, M Micksche
PMCID: PMC370231  PMID: 6211464

Abstract

T cells proliferate in response to autologous non-T cells in the autologous mixed lymphocyte reaction (AMLR). AMLR was impaired in the peripheral blood of patients with advanced lung cancer (4,159 +/- 3,878 delta cpm vs. 11,221 +/- 4,156 delta cpm for normal donors) but normal or even higher in their malignant pleural effusions (13,257 +/- 7,075 delta cpm vs. 10, 870 +/- 5,013 delta cpm for nonmalignant control effusions). Blood T cells also failed to respond to autologous effusion non-T cells, while effusion T cells strongly responded to autologous erythrocytes blood non-T cells. The presence of blood T cells did not inhibit effusion AMLR of the same patients. A subset of T cells that form rosettes with autologous erythrocytes if found to proliferate in AMLR. The number of autorosette-forming cells was lower in blood T cells of cancer patients than in blood T cells of normal donors and in effusion T cells of the patients. After enrichment of autorosette-forming cells, there was no difference in AMLR of normal blood and cancer blood and effusions. These results indicate that the loss of AMLR in the blood of cancer patients is due to a reduction of number of autoreactive T cells and not to a defect of autologous stimulator non-T cells.

Full text

PDF
98

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beale M. G., MacDermott R. P., Stacey M. C., Nash G. S., Hahn B. H., Seiden M. V., Jacobs S. L., Loewenstein L. S. Stimulating cell types in the autologous mixed leukocyte reaction in man. J Immunol. 1980 Jan;124(1):227–232. [PubMed] [Google Scholar]
  2. Damle N. K., Hansen J. A., Good R. A., Gupta S. Monoclonal antibody analysis of human T lymphocyte subpopulations exhibiting autologous mixed lymphocyte reaction. Proc Natl Acad Sci U S A. 1981 Aug;78(8):5096–5098. doi: 10.1073/pnas.78.8.5096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dean J. H., Connor R., Herberman R. B., Silva J., McCoy J. L., Oldham R. K. The relative proliferation index as a more sensitive parameter for evaluating lymphoproliferative responses of cancer patients to mitogens and alloantigens. Int J Cancer. 1977 Sep 15;20(3):359–370. doi: 10.1002/ijc.2910200307. [DOI] [PubMed] [Google Scholar]
  4. Engleman E. G., Benike C. J., Hoppe R. T., Kaplan H. S., Berberich F. R. Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect. J Clin Invest. 1980 Jul;66(1):149–158. doi: 10.1172/JCI109828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fournier C., Charreire J. Autologous mixed lymphocyte reaction in man. I. Relationship with age and sex. Cell Immunol. 1981 May 1;60(1):212–219. doi: 10.1016/0008-8749(81)90261-6. [DOI] [PubMed] [Google Scholar]
  6. Golub S. H., O'Connell T. X., Morton D. L. Correlation of in vivo and in vitro assays of immunocompetence in cancer patients. Cancer Res. 1974 Aug;34(8):1833–1837. [PubMed] [Google Scholar]
  7. Hausman P. B., Stobo J. D. Specificity and function of a human autologous reactive T cell. J Exp Med. 1979 Jun 1;149(6):1537–1542. doi: 10.1084/jem.149.6.1537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jerrells T. R., Dean J. H., Richardson G. L., McCoy J. L., Herberman R. B. Role of suppressor cells in depression of in vitro lymphoproliferative responses of lung cancer and breast cancer patients. J Natl Cancer Inst. 1978 Oct;61(4):1001–1009. [PubMed] [Google Scholar]
  9. Kuntz M. M., Innes J. B., Weksler M. E. Lymphocyte transformation induced by autologous cells. IV. Human T-lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes. J Exp Med. 1976 May 1;143(5):1042–1054. doi: 10.1084/jem.143.5.1042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kuntz M. M., Innes J. B., Weksler M. E. The cellular basis of the impaired autologous mixed lymphocyte reaction in patients with systemic lupus erythematosus. J Clin Invest. 1979 Jan;63(1):151–153. doi: 10.1172/JCI109270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Miyasaka N., Sauvezie B., Pierce D. A., Daniels T. E., Talal N. Decreased autologous mixed lymphocyte reaction in Sjögren's syndrome. J Clin Invest. 1980 Nov;66(5):928–933. doi: 10.1172/JCI109960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Moody C. E., Casazza B. A., Christenson W. N., Weksler M. E. Lymphocyte transformation induced by autologous cells. VIII. Impaired autologous mixed lymphocyte reactivity in patients with acute infectious mononucleosis. J Exp Med. 1979 Dec 1;150(6):1448–1455. doi: 10.1084/jem.150.6.1448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Opelz G., Kiuchi M., Takasugi M., Terasaki P. I. Autologous stimulation of human lymphocyte subpopulation. J Exp Med. 1975 Nov 1;142(5):1327–1333. doi: 10.1084/jem.142.5.1327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Palacios R., Llorente L., Alarcón-Segovia D., Ruíz-Arguelles A., Díaz-Jouanen E. Autologous rosette-forming T cells as the responding cells in human autologous mixed-lymphocyte reaction. J Clin Invest. 1980 Jun;65(6):1527–1530. doi: 10.1172/JCI109819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rees J. C., Rossio J. L., Wilson H. E., Minton J. P., Dodd M. C. Cellular immunity in neoplasia. Antigen and mitogen responses in patients with bronchiogenic carcinoma. Cancer. 1975 Dec;36(6):2010–2015. doi: 10.1002/cncr.2820360913. [DOI] [PubMed] [Google Scholar]
  16. Sakane T., Green I. Specificity and suppressor function of human T cells responsive to autologous non-T cells. J Immunol. 1979 Aug;123(2):584–589. [PubMed] [Google Scholar]
  17. Sakane T., Steinberg A. D., Green I. Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3464–3468. doi: 10.1073/pnas.75.7.3464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Smith J. B., Knowlton R. P. Activation of suppressor T cells in human autologous mixed lymphocyte culture. J Immunol. 1979 Jul;123(1):419–422. [PubMed] [Google Scholar]
  19. Smith J. B., Knowlton R. P., Koons L. S. Immunologic studies in chronic lymphocytic leukemia: defective stimulation of T-cell proliferation in autologous mixed lymphocyte culture. J Natl Cancer Inst. 1977 Mar;58(3):579–585. doi: 10.1093/jnci/58.3.579. [DOI] [PubMed] [Google Scholar]
  20. Takasugi M., Kiuchi M., Opelz G. Lymphocyte interactions in autologous and allogeneic reactions. Transplant Proc. 1977 Mar;9(1):789–792. [PubMed] [Google Scholar]
  21. Uchida A., Hoshino T. Clinical studies on cell-mediated immunity in patients with malignant disease. I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsiveness in vitro. Cancer. 1980 Feb;45(3):476–483. doi: 10.1002/1097-0142(19800201)45:3<476::aid-cncr2820450311>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  22. Uchida A., Hoshino T. Reduction of suppressor cells in cancer patients treated with OK-432 immunotherapy. Int J Cancer. 1980 Oct 15;26(4):401–404. doi: 10.1002/ijc.2910260403. [DOI] [PubMed] [Google Scholar]
  23. Uchida A., Micksche M. Reactivity to autologous non-T-cells and suppressor function of human autologous rosettes. Immunol Lett. 1981 Aug;3(3):145–149. doi: 10.1016/0165-2478(81)90117-6. [DOI] [PubMed] [Google Scholar]
  24. Weksler M. E., Birnbasum G. Lymphocyte transformation induced by autologous cells: stimulation by cultured lymphoblast lines. J Clin Invest. 1972 Dec;51(12):3124–3132. doi: 10.1172/JCI107139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Weksler M. E., Kozak R. Lymphocyte transformation induced by autologous cells. V. Generation of immunologic memory and specificity during the autologous mixed lymphocyte reaction. J Exp Med. 1977 Dec 1;146(6):1833–1838. doi: 10.1084/jem.146.6.1833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Zembala M., Mytar B., Popiela T., Asherson G. L. Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: the role of suppressor cells. Int J Cancer. 1977 May 15;19(5):605–613. doi: 10.1002/ijc.2910190503. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES